Biblio

Export 21 results:
Author Title Type [ Year(Asc)]
2016
Eekers D, Roelofs E, Jelen U, Kirk M, Granzier M, Ammazzalorso F, et al.. Data from: Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicenter in silico ROCOCO trial. 2016.
Reymen B, van Gisbergen MW, Even AJG, Zegers CML, Oberije C, Mottaghy F, et al.. Data from: Nitroglycerin in non-small cell lung cancer: does it impact tumor hypoxia and tumor perfusion? A window-of-opportunity clinical trial. 2016. Package icon Reymen_Nitro_database_HX-4_DCECT.zip (5.1 KB)
Carvalho S, Troost EGC, Bons J, Menheere P, Lambin P, Oberije C. Data from: Prognostic value of blood-biomarkers related to hypoxia, inflammation, immune response and tumour load in non-small cell lung cancer – a survival model with external validation. 2016. File carvalho-prognostic-biomarkers-NSCLC.xlsx (69.51 KB)
Even A, Hamming-Vrieze O, van Elmpt W, Winnepenninckx V, Heukelom J, Tesselaar M, et al.. Data from: Quantitative assessment of Zirconium-89 labeled cetuximab using PETCT imaging in patients with advanced head and neck cancer - a theragnostic approach. 2016. Package icon Even_P0037C0006I4475579.ZIP (97.26 MB)Package icon Even_P0037C0006I5879176.ZIP (131.21 MB)Package icon Even_P0037C0006I6042760.ZIP (115.71 MB)Package icon Even_P0037C0006I8991415.ZIP (101.03 MB)
Roelofs E. From Data to Decision - A Knowledge Engineering approach to individualise cancer therapy. GROW - School for Oncology and Developmental Biology. [Maastricht]: Maastricht University; 2016. p. 175. PDF icon Dissertation - full (6.52 MB)PDF icon Propositions (51.51 KB)
Lambin P. Radiomics Digital Phantom. CancerData; 2016. Package icon PHANTOM_DICOM.zip (7.73 MB)Package icon GTV_B_DICOM.zip (281.74 KB)Package icon GTV_M_DICOM.zip (175.39 KB)Package icon GTV_O_DICOM.zip (421.42 KB)
2015
Walsh S, Roelofs E, Kuess P, Lambin P, Jones B, Georg D, et al.. Data from: A validated Tumor Control Probability model based on a meta-analysis of low, intermediate, and high-risk prostate cancer patients treated by photon, proton, or carbon-ion radiotherapy [Internet]. 2015. https://www.cancerdata.org/resource/doi:10.17195/candat.2015.10.8File Walsh - TCP meta-analysis of patients treated with photon, proton and c-ion radiotherapy (CSV) (15.82 KB)File Walsh - TCP meta-analysis of patients treated with photon, proton and c-ion radiotherapy (XLS) (13.85 KB)
Cheng Q, Roelofs E, Ramaekers B, Eekers D, van Soest J, Lustberg T, et al.. Data from: Development and Evaluation of an Online Three-Level Proton vs Photon Decision Support Prototype for Head and Neck Cancer - Comparison of Dose, Toxicity and Cost-Effectiveness [Internet]. CancerData; 2015. https://www.cancerdata.org/resource/doi:10.17195/candat.2015.10.5File PRODECIS-HNC-results.xlsx (43.25 KB)Image icon PRODECIS-HNC-Figure-2.png (47.07 KB)
Panth K, van den Beucken T, Biemans R, Lieuwes N, Weber M, Losen M, et al.. Data from: MMP2 small immuno protein antibody uptake in xenograft tumors is associated with MMP2 activity [Internet]. CancerData; 2015. https://www.cancerdata.org/resource/doi:10.17195/candat.2015.10.6File Panth_MMP2-activity-vs-uptake.csv (2.03 KB)File Panth_MMP2-analysis.csv (6.1 KB)File Panth_MMP2-representative-images.rar (570.44 KB)
Even AJG, van der Stoep J, Zegers CML, Reymen B, Troost EGC, Lambin P, et al.. PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes. Radiother Oncol. 2015;116(2):281-6.
Oberije C, De Ruysscher D, Houben R, van de Heuvel M, Uyterlinde W, Deasy JO, et al.. A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients. Int J Radiat Oncol Biol Phys. 2015;92(4):935-44.